The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn AP's BPC 157 peptide warning skips every doctor who disagrees Seattle Red Ohio Med Spas: Peptide Do's and Do Not's FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC